NASDAQ:ECOR electroCore (ECOR) Stock Price, News & Analysis → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free ECOR Stock Alerts $6.32 +0.20 (+3.27%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share Today's Range$6.14▼$6.4550-Day Range$5.51▼$7.0052-Week Range$3.83▼$8.08Volume6,400 shsAverage Volume12,569 shsMarket Capitalization$37.92 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get electroCore alerts: Email Address electroCore MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy0.18% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.19Based on 4 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($1.59) to ($0.33) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.72 out of 5 starsMedical Sector820th out of 904 stocksElectromedical Equipment Industry19th out of 20 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for electroCore. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.18% of the float of electroCore has been sold short.Short Interest Ratio / Days to CoverelectroCore has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in electroCore has recently decreased by 12.87%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldelectroCore does not currently pay a dividend.Dividend GrowthelectroCore does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for ECOR. Previous Next 2.3 News and Social Media Coverage News SentimentelectroCore has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.41 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for electroCore this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ECOR on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows1 people have added electroCore to their MarketBeat watchlist in the last 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, electroCore insiders have not sold or bought any company stock.Percentage Held by Insiders13.14% of the stock of electroCore is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 26.74% of the stock of electroCore is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for electroCore are expected to grow in the coming year, from ($1.59) to ($0.33) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of electroCore is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of electroCore is -1.78, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioelectroCore has a P/B Ratio of 5.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Banyan Hill PublishingForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsIf you think AI is big, then you have got to check out something I call Imperium… By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.)Watch my video for all of the details About electroCore Stock (NASDAQ:ECOR)electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Read More ECOR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ECOR Stock News HeadlinesMay 3, 2024 | globenewswire.comelectroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)May 1, 2024 | globenewswire.comelectroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024May 6, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 30, 2024 | finance.yahoo.comTruvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market ExpansionApril 30, 2024 | globenewswire.comTruvaga™ Plus Demonstrates Health Benefits in Latest Consumer Study, Paving the Way for Market ExpansionApril 18, 2024 | finance.yahoo.comelectroCore, Inc. (ECOR) Interactive Stock Chart - Yahoo FinanceApril 18, 2024 | finance.yahoo.comelectroCore, Inc. (ECOR)April 8, 2024 | globenewswire.comelectroCore Announces the Launch of Truvaga Plus® for General WellnessMay 6, 2024 | Paradigm Press (Ad)Dems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.April 2, 2024 | globenewswire.comelectroCore Expands Intellectual Property PortfolioMarch 16, 2024 | finance.yahoo.comelectroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | seekingalpha.comelectroCore, Inc. (ECOR) Q4 2023 Earnings Call TranscriptMarch 15, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Electrocore (ECOR), Viking Therapeutics (VKTX)March 14, 2024 | finanznachrichten.deelectroCore, Inc.: electroCore Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 14, 2024 | finance.yahoo.comQ4 2023 electroCore, Inc. Earnings CallMarch 14, 2024 | finance.yahoo.comelectroCore Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 13, 2024 | globenewswire.comelectroCore Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 12, 2024 | msn.comElectroCore Q4 2023 Earnings PreviewMarch 12, 2024 | markets.businessinsider.comHere's what to expect from electroCore's earningsMarch 12, 2024 | globenewswire.comelectroCore to Participate in Upcoming Investor ConferencesMarch 5, 2024 | globenewswire.comelectroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024February 19, 2024 | lse.co.ukEcora Res. Share ChatFebruary 15, 2024 | morningstar.comEcora Resources PLC ECORJanuary 12, 2024 | finance.yahoo.comelectroCore, Inc. (ECOR) Stock Historical Prices & Data - Yahoo FinanceJanuary 11, 2024 | finanznachrichten.deelectroCore, Inc.: electroCore Expands Intellectual Property PortfolioDecember 26, 2023 | finance.yahoo.comelectroCore Expands Intellectual Property PortfolioDecember 12, 2023 | finance.yahoo.comelectroCore Expands Intellectual Property Portfolio for Nerve Stimulation TechnologySee More Headlines Receive ECOR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for electroCore and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/13/2024Today5/05/2024Next Earnings (Confirmed)5/08/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryN/A Current SymbolNASDAQ:ECOR CUSIPN/A CIK1560258 Webwww.electrocore.com Phone(973) 290-0097FaxN/AEmployees68Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,830,000.00 Net Margins-117.49% Pretax Margin-118.65% Return on Equity-201.47% Return on Assets-109.61% Debt Debt-to-Equity RatioN/A Current Ratio1.76 Quick Ratio1.49 Sales & Book Value Annual Sales$16.03 million Price / Sales2.37 Cash FlowN/A Price / Cash FlowN/A Book Value$1.24 per share Price / Book5.10Miscellaneous Outstanding Shares6,000,000Free Float5,214,000Market Cap$37.95 million OptionableNot Optionable Beta0.91 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Daniel S. Goldberger (Age 65)CEO & Director Comp: $1.05MDr. Thomas J. Errico M.D. (Age 72)Founder, Independent Director & Principal Investor Comp: $58.12kMr. Brian M. Posner CPA (Age 62)MBA., CFO & Corporate Secretary Comp: $599.88kMr. Michael Romaniw (Age 67)Executive Vice President of Systems & Operations Mr. Mitch DeshonVice President of Global Sales & Business DevelopmentMs. Carrie KochekSenior Director of Human ResourcesDr. Peter S. Staats M.B.A. (Age 60)M.D., Chief Medical Officer Comp: $238.41kMr. Joshua S. LevChief Strategy OfficerMr. Manuel A. Marques (Age 51)Senior Vice President of Operations Ms. Amanda YanuklisChief of StaffMore ExecutivesKey CompetitorsPixie Dust TechnologiesNASDAQ:PXDTPrecision OpticsNASDAQ:POCIRockwell MedicalNASDAQ:RMTIMovanoNASDAQ:MOVEIRIDEXNASDAQ:IRIXView All CompetitorsInsiders & InstitutionsPFG Investments LLCBought 18,000 shares on 4/22/2024Ownership: 0.300%International Assets Investment Management LLCBought 17,620 shares on 4/11/2024Ownership: 0.883%Daniel S GoldbergerBought 1,500 shares on 9/15/2023Total: $8,325.00 ($5.55/share)Daniel S GoldbergerBought 50,991 shares on 8/2/2023Total: $221,810.85 ($4.35/share)View All Insider TransactionsView All Institutional Transactions ECOR Stock Analysis - Frequently Asked Questions Should I buy or sell electroCore stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ECOR shares. View ECOR analyst ratings or view top-rated stocks. How have ECOR shares performed in 2024? electroCore's stock was trading at $5.95 at the beginning of 2024. Since then, ECOR shares have increased by 6.2% and is now trading at $6.32. View the best growth stocks for 2024 here. Are investors shorting electroCore? electroCore saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 8,800 shares, a drop of 12.9% from the March 31st total of 10,100 shares. Based on an average trading volume of 10,400 shares, the short-interest ratio is currently 0.8 days. Currently, 0.2% of the shares of the stock are sold short. View electroCore's Short Interest. When is electroCore's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our ECOR earnings forecast. How can I listen to electroCore's earnings call? electroCore will be holding an earnings conference call on Wednesday, May 8th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link. How were electroCore's earnings last quarter? electroCore, Inc. (NASDAQ:ECOR) released its earnings results on Wednesday, March, 13th. The company reported ($0.61) earnings per share for the quarter, missing analysts' consensus estimates of ($0.55) by $0.06. The business had revenue of $5.19 million for the quarter, compared to analysts' expectations of $5.23 million. electroCore had a negative trailing twelve-month return on equity of 201.47% and a negative net margin of 117.49%. During the same quarter in the previous year, the company earned ($1.22) EPS. When did electroCore's stock split? electroCore's stock reverse split before market open on Tuesday, February 14th 2023. The 1-15 reverse split was announced on Tuesday, February 14th 2023. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 14th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. What other stocks do shareholders of electroCore own? Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK). When did electroCore IPO? electroCore (ECOR) raised $64 million in an initial public offering on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities served as the underwriters for the IPO and BTIG was co-manager. Who are electroCore's major shareholders? electroCore's stock is owned by a number of institutional and retail investors. Top institutional investors include International Assets Investment Management LLC (0.88%) and PFG Investments LLC (0.30%). Insiders that own company stock include Brian M Posner, Daniel S Goldberger, John P Gandolfo, Joseph P Errico, Thomas J Errico, Thomas J Errico and Trevor J Moody. View institutional ownership trends. How do I buy shares of electroCore? Shares of ECOR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:ECOR) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsElon to Transform U.S. Economy? Porter & CompanyCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithIs Tesla going out of business?DTIStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding electroCore, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
